| Literature DB >> 32497355 |
Mirkamal Tolend1,2, Haris Majeed1,2, Magdy Soliman2, Paulo Daruge3, Marcelo Bordalo-Rodrigues3, Sergio San Juan Dertkigil4, Sridhar Gibikote5, Shyamkumar N Keshava5, Jennifer Stimec2,6, Amy Dunn7, Ying-Jia Li8, Victor Blanchette9, Björn Lundin10, Andrea S Doria2,6.
Abstract
A goal of the International Prophylaxis Study Group (IPSG) is to provide an accurate instrument to measure MRI-based disease severity of haemophilic arthropathy at various time points, so that longitudinal changes in disease severity can be identified to support decisions on treatment management. We review and discuss in this paper the evaluative purpose of the IPSG MRI scale in relation to its development and validation processes so far. We also critically appraise the validity, reliability and responsiveness of using the IPSG MRI scale in different clinical and research settings, and whenever applicable, compare these clinimetric properties of the IPSG MRI scale with those of its precursors, the compatible additive and progressive MRI scales.Entities:
Keywords: International Prophylaxis Study Group; children; hemophilic arthropathy; joints; magnetic resonance imaging; responsiveness; validity
Mesh:
Substances:
Year: 2020 PMID: 32497355 DOI: 10.1111/hae.14032
Source DB: PubMed Journal: Haemophilia ISSN: 1351-8216 Impact factor: 4.287